Mark C. Schneyer Acadia Pharmaceuticals Inc (ACAD) insider trading activity

ACAD Quotes by TradingView

Mark C. Schneyer is EVP, CHIEF FINANCIAL OFFICER of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 53,302 shares of ACAD, which is worth approximately $868,822. The most recent transaction as insider was on Jun 09, 2022, when has been sold 653 shares (Common Stock) at a price of $17.91 per share, resulting in proceeds of $11,695. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.3K
21.87% 3M change
160.19% 12M change
Total Value Held $868,822

Mark C. Schneyer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2022
SELL
Open market or private sale
$11,695 $17.91 p/Share
653 Reduced 16.35%
3,342 Common Stock
Jun 08 2022
BUY
Exercise of conversion of derivative security
-
1,893 Added 32.15%
3,995 Common Stock
Feb 23 2022
SELL
Open market or private sale
$13,161 $23.8 p/Share
553 Reduced 20.83%
2,102 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
-
1,352 Added 33.74%
2,655 Common Stock
MCS

Mark C. Schneyer

EVP, CHIEF FINANCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACAD